United Kingdom

In the UK, Nettle™ is not currently reimbursed through standard private health insurance policies or routinely available via the NHS.

Nettle™ is currently being piloted at one NHS site, and we’re working closely with clinical partners to evaluate outcomes and explore pathways to make access more widespread, with the aim of broader availability by 2030.

If you have private health insurance, you can speak directly with your insurer about whether they would consider covering Nettle™ as a Class IIa medical device, particularly if it is recommended by your clinician. Coverage decisions vary by insurer and by individual policy, and acceptance is not guaranteed.

At this stage, eligibility and access decisions are made by the NHS, insurers, or other third-party organisations — not by us. We’ll continue to update our guidance as these pathways evolve.